CDC warns of a summer spike in rabies exposures
The story so far
- Velocity & Diffusion: Coverage escalated across 13 distinct news outlets with 16 published articles, achieving a live velocity of 14.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"CDC warns of a summer spike in rabies exposures" developed substantial multi-source reporting across the Health sector, tracked across 13 distinct newsrooms by Newsylist.
Key reporting was led by WLOS, SFGATE, Yahoo and Yahoo News Canada. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
Sources (16)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
New CDC alert warns that exposure to rabies is on the rise in United States Baltimore Sun · 5d ago broke it first
The obvious questions
What drove coverage for CDC warns of a summer spike in rabies exposures?
Coverage spiked when 13 independent newsrooms published 16 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Measles Is the Deadly Disease of America’s Trust Crisis
Yankee Stadium cooling tower tests positive for Legionella, NYC says
Pennsylvania woman dies of measles-related complications, local coroner says
Want to lower your risk of dementia? It doesn’t involve a blood test
U. grad with stage 4 cancer heads to Washington to push for clinical trial access
A university graduate with stage 4 cancer is heading to Washington to advocate for clinical trial access.